| Detected | Trial | Change |
|---|---|---|
| 2026-08-14 | NCT04628871 Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX |
critical Trial terminated |
| 2026-08-14 | NCT04628871 Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX |
critical Trial terminated: Sangamo declared Chapter 11 Bankruptcy on 23Jun2026 and terminated the study on 21Jul2026. |
| 2026-08-14 | NCT04628871 Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX |
date change Primary completion moved earlier: 2030-01-01 -> 2026-06-17 |
| 2026-08-14 | NCT04628871 Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX |
date change Completion moved earlier: 2030-01-01 -> 2026-06-17 |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1/2 | |||
| NCT06980948 | Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy… | Chronic Neuropathic Pain | Recruiting |
| Not specified | |||
| NCT05039866 | Long-Term Follow-up of Subjects Who Were Treated With ST-920 | Fabry Disease | Enrolling by Invitation |
| NCT05145062 | Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously… | Blood and Lymphatic Diseases | Active, Not Recruiting |
| NCT05987527 | Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term) | Kidney Transplant Rejection | Active, Not Recruiting |